EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk assessment and mitigation of hepatitis C virus RNA carryover contamination in a reflex testing algorithm

Victoria Stepanyants iD, Emily Hallock, Mary Kathryn Doud, Erika Harrington, Anthony Leung, Kamran Kadkhoda iD, Hannah Wang iD

Journal of Clinical Microbiology · 12.08.2026 · 64 (8)

DOI: 10.1128/jcm.00256-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 12.08.2026. Verfasst von Victoria Stepanyants und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: RNA, Viral, Hepacivirus, Hepatitis C, Specimen Handling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Laboratory-based diagnosis of active hepatitis C virus (HCV) infection currently requires a positive antibody test and a confirmatory RNA test. Many institutions in the United States continue to require two separate sample collections, partially due to concerns for carryover contamination. Reflexive RNA testing of antibody-positive samples reduces loss to follow-up, improves linkage to care, and is a recommended operational strategy by the Centers for Disease Control and Prevention. This study describes false positivity rates of reflexive RNA testing in a reference laboratory before and after introduction of a risk mitigation strategy that requires medical director review for reflexed HCV viral loads < 1,000 IU/mL (defined as low-positive). Initial HCV antibody testing was performed at one of five chemistry laboratories; reflex HCV RNA testing was performed using the cobas HCV assay on cobas 8800 (Roche) at a central reference laboratory. A total of 4,079 consecutive positive RNA results were included pre-intervention, and 4,433 were included post-intervention. All low-positive results ( N = 157) were retrospectively adjudicated as true-positive ( N = 66), false-positive ( N = 38), or unknown ( N = 53), based on clinical history and redraw results. The pre-intervention false-positive rate was 0.44%, which was significantly reduced to 0.14% post-intervention, P = 0.008. Median viral load for those clinically adjudicated as true-positive was significantly higher at 97 IU/mL (IQR: 24, 330 IU/mL) compared to 17 IU/mL (IQR: 14, 58 IU/mL) classified as false-positive or 16 IU/mL (IQR: 14, 62 IU/mL) classified as unknown. This study supports wider implementation of reflexive RNA testing for antibody-positive samples and provides a blueprint for a risk mitigation strategy. IMPORTANCE Most patients infected with hepatitis C virus are unable to spontaneously clear the virus and develop chronic infection. Chronic hepatitis C virus (HCV) infection can lead to life-threatening complications including liver cirrhosis, liver failure, and liver cancer. Therefore, accurate diagnosis of hepatitis C infection and linkage to treatment is paramount. To increase linkage to care, current Centers for Disease Control and Prevention (CDC) guidelines recommend single-visit sample collection to test for antibodies and, if antibody positive, viral RNA. However, almost half of the laboratories do not use reflexive testing strategies, in part due to concerns for carryover contamination. Our study describes a low risk of false-positive RNA results and suggests a risk mitigation intervention to further minimize false positives. Our work reaffirms CDC guidelines and provides real-world data to encourage other facilities to follow a reflex testing algorithm to increase linkage to care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, ViralHepacivirusHepatitis CSpecimen HandlingHumansFalse Positive ReactionsRisk AssessmentViral LoadAlgorithmsUnited StatesRetrospective StudiesMolecular Diagnostic TechniquesHepatitis C Antibodies

Stichwörter der Autor:innen

clinical laboratory information systemsdiagnostic techniqueshealth services administrationhepacivirushepatitis viruseslaboratories

Substanzen

RNA, ViralHepatitis C Antibodies

Autor:innen und Institutionen

  • Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Pharmacy, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Infectious Diseases, Cleveland Clinic Foundation, Akron, Ohio, USA.

ORCID-Profile: Victoria Stepanyants, Kamran Kadkhoda, Hannah Wang

Zitieren

APA

Stepanyants, V., Hallock, E., Doud, M. K., Harrington, E., Leung, A., Kadkhoda, K., & Wang, H. (2026). Risk assessment and mitigation of hepatitis C virus RNA carryover contamination in a reflex testing algorithm. Journal of Clinical Microbiology, 64(8). https://doi.org/10.1128/jcm.00256-26

Vancouver

Stepanyants V, Hallock E, Doud MK, Harrington E, Leung A, Kadkhoda K, et al. Risk assessment and mitigation of hepatitis C virus RNA carryover contamination in a reflex testing algorithm. Journal of Clinical Microbiology. 2026;64(8). doi:10.1128/jcm.00256-26

BibTeX
@article{Stepanyants2026,
  author = {Stepanyants, Victoria and Hallock, Emily and Doud, Mary Kathryn and Harrington, Erika and Leung, Anthony and Kadkhoda, Kamran and Wang, Hannah},
  title = {Risk assessment and mitigation of hepatitis C virus RNA carryover contamination in a reflex testing algorithm},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {8},
  doi = {10.1128/jcm.00256-26}
}
Kostenlos starten →